Ectopic dopaminergic progenitor cells from En1 +/Otx2lacZ transgenic mice survive and functionally reinnervate the striatum following transplantation in a rat model of Parkinson's disease

Cell Transplantation

Volumn 19, Issue 9, 2010, Pages 1085-1101

  Hackl, Christina ^a   Papazoglou, Anna ^a   Ganser, Claudia ^a   Klein, Alexander ^a   Prakash, Nilima ^b   Wurst, Wolfgang ^b   Nikkhah, Guido ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

DA progenitor domain; Midbrain hindbrain boundary; Neuron cell transplantation; Nucleus raphe; Orthodenticle homolog 2 (Otx2); Ventral mesencephalon

Indexed keywords

AMPHETAMINE; OXIDOPAMINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DNA MODIFICATION; ECTOPIC DOPAMINERGIC PROGENITOR CELL; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MOUSE; NEUROBIOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REINNERVATION; RHOMBENCEPHALON; SEROTONINERGIC NERVE CELL; STEM CELL; STEM CELL TRANSPLANTATION; TRANSGENIC MOUSE;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NEURAL STEM CELLS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION;

ANIMALIA; MUS; MUS MUSCULUS; RATTUS;

EID: 78649902416     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X505468     Document Type: Article

References (46)

1. Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247; 1946.
2. Astradsson, A.; Cooper, O.; Vinuela, A.; Isacson, O. Recent advances in cell-based therapy for Parkinson disease. Neurosurg. Focus. 24:E6; 2008.
3. Bagga, V.; Dunnett, S. B.; Fricker-Gates, R. A. Ascorbic acid increases the number of dopamine neurons in vitro and in transplants to the 6-OHDA-lesioned rat brain. Cell Transplant. 17:763-773; 2008.
4. Björklund, A. Fluorescence histochemistry of biogenic monoamines. In: Björklund, A.; Hökfelt, T., eds. Handbook of chemical neuroanatomy, vol. 1. Amsterdam, The Netherlands: Elsevier Science Publisher B. V.; 1983:50-121.
5. Braak, H.; Del Tredici, K. Assessing fetal nerve cell grafts in Parkinson's disease. Nat. Med. 14:483-485; 2008.
6. Broccoli, V.; Boncinelli, E.; Wurst, W. The caudal limit of Otx2 expression positions the isthmic organizer. Nature 401:164-168; 1999.
7. Brodski, C.; Weisenhorn, D. M.; Signore, M.; Sillaber, I.; Oesterheld, M.; Broccoli, V.; Acampora, D.; Simeone, A.; Wurst, W. Location and size of dopaminergic and seroton- ergic cell populations are controlled by the position of the midbrain-hindbrain organizer. J. Neurosci. 23:4199-4207; 2003.
8. Carlsson, T.; Carta, M.; Winkler, C.; Björklund, A.; Kirik, D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J. Neurosci. 27:8011-8022; 2007.
9. Carta, M.; Carlsson, T.; Kirik, D.; Björklund, A. Dopamine released from 5-HT terminals is the cause of LDOPA- induced dyskinesia in parkinsonian rats. Brain 130:1819-1833; 2007.
10. Chung, S.; Leung, A.; Han, B. S.; Chang, M. Y.; Moon, J. I.; Kim, C. H.; Hong, S.; Pruszak, J.; Isacson, O.; Kim, K. S. Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell 5: 646-658; 2009.
11. Deierborg, T.; Soulet, D.; Roybon, L.; Hall, V.; Brundin, P. Emerging restorative treatments for Parkinson's disease. Prog. Neurobiol. 85:407-432; 2008.
12. Duan, W. M.; Widner, H.; Brundin, P. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp. Brain Res. 104:227-242; 1995.
13. Falkenstein, G.; Rosenthal, C.; Reum, T.; Morgenstern, R.; Dobrossy, M.; Nikkhah, G. Pattern of long-term sensorimotor recovery following intrastriatal and-accumbens DA micrografts in a rat model of Parkinson's disease. J. Comp. Neurol. 515:41-55; 2009.
14. Gundersen, H. J.; Bendtsen, T. F.; Korbo, L.; Marcussen, N.; Moller, A.; Nielsen, K.; Nyengaard, J. R.; Pakkenberg, B.; Sorensen, F. B.; Vesterby, A.; West, M. J. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379-394; 1988.
15. Hahn, M.; Timmer, M.; Nikkhah, G. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease. J. Neurosci. Res. 87:2006-2019; 2009.
16. Hall, V. J.; Li, J. Y.; Brundin, P. Restorative cell therapy for Parkinson's disease: A quest for the perfect cell. Semin. Cell Dev. Biol. 18:859-869; 2007.
17. Hudson, J.; Granholm, A. C.; Gerhardt, G. A.; Henry, M. A.; Hoffman, A.; Biddle, P.; Leela, N. S.; Mackerlova, L.; Lile, J. D.; Collins, F.; Hoffer, B. J. Glial cell line- derived neurotrophic factor augments midbrain dopamin-ergic circuits in vivo. Brain Res. Bull. 36:425-432; 1995.
18. Isacson, O.; Kordower, J. H. Future of cell and gene therapies for Parkinson's disease. Ann. Neurol. 64(Suppl. 2): S122-S138; 2008.
19. Kawasaki, H.; Mizuseki, K.; Nishikawa, S.; Kaneko, S.; Kuwana, Y.; Nakanishi, S.; Nishikawa, S. I.; Sasai, Y. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40; 2000.
20. Lane, E. L.; Brundin, P.; Cenci, M. A. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. Neurobiol. Dis. 35:42-51; 2009.
21. Lindvall, O.; Kokaia, Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol. Sci. 30:260-267; 2009.
22. Mayhew, T. M. A review of recent advances in stereology for quantifying neural structure. J. Neurocytol. 21:313-328; 1992.
23. McKay, R.; Kittappa, R. Will stem cell biology generate new therapies for Parkinson's disease? Neuron 58:659-661; 2008.
24. Mendez, I.; Sanchez-Pernaute, R.; Cooper, O.; Vinuela, A.; Ferrari, D.; Bjorklund, L.; Dagher, A.; Isacson, O. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128:1498-1510; 2005.
25. Monahan, A. J.; Warren, M.; Carvey, P. M. Neuroinflammation and peripheral immune infiltration in Parkinson's disease: An autoimmune hypothesis. Cell Transplant. 17: 363-372; 2008.
26. Munoz, A.; Li, Q.; Gardoni, F.; Marcello, E.; Qin, C.; Carlsson, T.; Kirik, D.; Di Luca, M.; Björklund, A.; Bezard, E.; Carta, M. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain 131:3380-3394; 2008.
27. Nikkhah, G.; Cunningham, M. G.; Jodicke, A.; Knappe, U.; Bjorklund, A. Improved graft survival and striatal re- innervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 633: 133-143; 1994.
28. Nikkhah, G.; Olsson, M.; Eberhard, J.; Bentlage, C.; Cunningham, M. G.; Bjorklund, A. A microtransplantation approach for cell suspension grafting in the rat Par- kinson model: A detailed account of the methodology. Neuroscience 63:57-72; 1994.
29. Nikkhah, G.; Rosenthal, C.; Falkenstein, G.; Roedter, A.; Papazoglou, A.; Brandis, A. Microtransplantation of dopa- minergic cell suspensions: Further characterization and optimization of grafting parameters. Cell Transplant. 18: 119-133; 2009.
30. Nikkhah, G.; Winkler, C.; Roedter, A.; Samii, M. Micro- transplantation of nigral dopamine neurons: A "step-by-step" recipe. In: Dunnett, S. B.; Baker, G., eds. Cell and tissue transplantation in the CNS. Totowa, NJ: Humana Press Inc.; 2000:207-231.
31. Omodei, D.; Acampora, D.; Mancuso, P.; Prakash, N.; Di Giovannantonio, L. G.; Wurst, W.; Simeone, A. Anterior- posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon. Development 135:3459-3470; 2008.
32. Prakash, N.; Brodski, C.; Naserke, T.; Puelles, E.; Gogoi, R.; Hall, A.; Panhuysen, M.; Echevarria, D.; Sussel, L.; Weisenhorn, D. M.; Martinez, S.; Arenas, E.; Simeone, A.; Wurst, W. A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133:89-98; 2006.
33. Prakash, N.; Wurst, W. Development of dopaminergic neurons in the mammalian brain. Cell. Mol. Life Sci. 63: 187-206; 2006.
34. Prakash, N.; Wurst, W. Genetic networks controlling the development of midbrain dopaminergic neurons. J. Physiol. 575:403-410; 2006.
35. Savitt, J. M.; Dawson, V. L.; Dawson, T. M. Diagnosis and treatment of Parkinson disease: Molecules to medicine. J. Clin. Invest. 116:1744-1754; 2006.
36. Schein, J. C.; Hunter, D. D.; Roffler-Tarlov, S. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev. Biol. 204:432-450; 1998.
37. Singec, I.; Jandial, R.; Crain, A.; Nikkhah, G.; Snyder, E. Y. The leading edge of stem cell therapeutics. Annu. Rev. Med. 58:313-328; 2007.
38. Sladek, Jr., J. R.; Bjugstad, K. B.; Collier, T. J.; Bundock, E. A.; Blanchard, B. C.; Elsworth, J. D.; Roth, R. H.; Redmond, Jr., D. E. Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate. Cell Transplant. 17:427-444; 2008.
39. Smidt, M. P.; Burbach, J. P. How to make a meso- diencephalic dopaminergic neuron. Nat. Rev. Neurosci. 8: 21-32; 2007.
40. Takagi, Y.; Takahashi, J.; Saiki, H.; Morizane, A.; Hayashi, T.; Kishi, Y.; Fukuda, H.; Okamoto, Y.; Koyanagi, M.; Ideguchi, M.; Hayashi, H.; Imazato, T.; Kawasaki, H.; Suemori, H.; Omachi, S.; Iida, H.; Itoh, N.; Nakatsuji, N.; Sasai, Y.; Hashimoto, N. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 115:102-109; 2005.
41. Thompson, L.; Barraud, P.; Andersson, E.; Kirik, D.; Bjorklund, A. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 25: 6467-6477; 2005.
42. Torrente, Y.; Polli, E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant. 17: 1103-1113; 2008.
43. Ungerstedt, U.; Arbuthnott, G. W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24: 485-493; 1970.
44. Weyrauch, U. M.; Torres, E. M.; Baird, A. L.; Dunnett, S. B. A simple breeding protocol for the procurement of accurately staged rat donor embryos for neural transplantation. Cell Transplant. 18:471-476; 2009.
45. Winkler, C.; Kirik, D.; Bjorklund, A. Cell transplantation in Parkinson's disease: How can we make it work? Trends Neurosci. 28:86-92; 2005.
46. Wurst, W.; Bally-Cuif, L. Neural plate patterning: Upstream and downstream of the isthmic organizer. Nat. Rev. Neurosci. 2:99-108; 2001.